PFE dumps PFNX Lucentis-FoB program—PFNX shares rise anyhow due to anthrax study: http://finance.yahoo.com/news/pfenex-regain-full-rights-pf582-113000734.html http://finance.yahoo.com/news/pfenex-announces-positive-anthrax-vaccine-113000883.html A Lucentis FoB never seemed like a compelling business proposition, IMO.